Package 0904-7172-07

{"route": ["ORAL"], "spl_id": "e3e2c3b9-806a-4639-ab44-5c5b4bb1166e", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["a78b51c9-c944-4b00-af81-9ecbfbb29fd1"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0904-7172-07)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-7172-07", "marketing_start_date": "20190726"}], "brand_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "0904-7172_e3e2c3b9-806a-4639-ab44-5c5b4bb1166e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "0904-7172", "generic_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA212114", "marketing_category": "ANDA", "marketing_start_date": "20190726", "listing_expiration_date": "20261231"}